Trial Profile
Clinical Trials Insight: 700014050
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Apr 2009
Price :
$35
*
At a glance
- Drugs Valaciclovir (Primary)
- Indications Cytomegalovirus infections; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 17 Apr 2009 Status changed from recruiting to completed.
- 01 Feb 2009 Status change from recruiting to completed
- 25 Jul 2006 New trial record.